Patents by Inventor Reinhold Müller

Reinhold Müller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11913815
    Abstract: A metering console (100) includes a housing (110) adapted to allow flow of a liquid (F) therethrough. The housing (110) is adapted to attach with one or more gardening devices (132, 152). The metering console (100) includes a display (170) associated with the housing (110). The metering console (100) is characterized in that the display (170) is rotatably engaged with the housing (110) of the metering console (100) such that the display (170) rotates along a central axis (A-A?) of the housing (110).
    Type: Grant
    Filed: June 2, 2021
    Date of Patent: February 27, 2024
    Assignee: HUSQVARNA AB
    Inventors: Tobias Mack, Matthias Müller-Braun, Reinhold Steck
  • Publication number: 20220356523
    Abstract: Technology provided herein relates in part to methods, processes and apparatuses for non-invasive assessment of genetic variations.
    Type: Application
    Filed: March 25, 2022
    Publication date: November 10, 2022
    Applicant: Sequenom, Inc.
    Inventors: Charles R. Cantor, Grace DeSantis, Reinhold Mueller, Mathias Ehrich
  • Patent number: 11312997
    Abstract: Technology provided herein relates in part to methods, processes and apparatuses for non-invasive assessment of genetic variations.
    Type: Grant
    Filed: May 27, 2020
    Date of Patent: April 26, 2022
    Assignee: Sequenom, Inc.
    Inventors: Charles R. Cantor, Grace DeSantis, Reinhold Mueller, Mathias Ehrich
  • Patent number: 11172793
    Abstract: Aspects of the present disclosure generally pertain to a devices for dampening inadvertent rollout of a paper roll. Generally, the disclosed dampening device for a paper roll is a device that rests on a bottom portion of an inner surface of a paper roll when the paper roll is installed in a horizontal orientation. The dampening device relies on its weight, to provide friction to resist rollout.
    Type: Grant
    Filed: January 30, 2019
    Date of Patent: November 16, 2021
    Inventor: Reinhold Mueller
  • Patent number: 11142164
    Abstract: Aspects of the present disclosure generally pertain to a vehicle inhibitor with an enhanced user interface and a system and method for overriding a vehicle inhibitor. This disclosure may be useful for providing an emergency override function for vehicle loan repayment enforcement systems that have wireless user interface modules, and that have become lost or inoperable when needed to generate an emergency override signal. Further, the present disclosure addresses this problem while mitigating additional system cost and additional components. This disclosure includes a method of providing an emergency override function for vehicle loan repayment enforcement systems that have wireless user interface modules, and that have become lost or inoperable when needed to generate an emergency override signal.
    Type: Grant
    Filed: August 7, 2020
    Date of Patent: October 12, 2021
    Inventors: Reinhold Mueller, Juan Carlos Vazquez
  • Publication number: 20200369239
    Abstract: Aspects of the present disclosure generally pertain to a vehicle inhibitor with an enhanced user interface and a system and method for overriding a vehicle inhibitor. This disclosure may be useful for providing an emergency override function for vehicle loan repayment enforcement systems that have wireless user interface modules, and that have become lost or inoperable when needed to generate an emergency override signal. Further, the present disclosure addresses this problem while mitigating additional system cost and additional components. This disclosure includes a method of providing an emergency override function for vehicle loan repayment enforcement systems that have wireless user interface modules, and that have become lost or inoperable when needed to generate an emergency override signal.
    Type: Application
    Filed: August 7, 2020
    Publication date: November 26, 2020
    Inventors: Reinhold MUELLER, Juan Carlos Vazquez
  • Publication number: 20200362412
    Abstract: Technology provided herein relates in part to methods, processes and apparatuses for non-invasive assessment of genetic variations.
    Type: Application
    Filed: May 27, 2020
    Publication date: November 19, 2020
    Applicant: Sequenom, Inc.
    Inventors: Charles R. Cantor, Grace DeSantis, Reinhold Mueller, Mathias Ehrich
  • Patent number: 10766457
    Abstract: Aspects of the present disclosure generally pertain to a system and method for overriding a vehicle inhibitor. This disclosure may be useful for providing an emergency override function for vehicle loan repayment enforcement systems that have wireless user interface modules, and that have become lost or inoperable when needed to generate an emergency override signal. Further, the present disclosure addresses this problem while mitigating additional system cost and additional components. This disclosure includes a method of providing an emergency override function for vehicle loan repayment enforcement systems that have wireless user interface modules, and that have become lost or inoperable when needed to generate an emergency override signal. Further this disclosure includes a method of providing a disablement override function for vehicle loan repayment enforcement systems, wired or wireless, that allows vehicle operation past the grace period in those locations where complete disablement may be limited.
    Type: Grant
    Filed: October 11, 2018
    Date of Patent: September 8, 2020
    Inventor: Reinhold Mueller
  • Patent number: 10738359
    Abstract: Technology provided herein relates in part to methods, processes and apparatuses for non-invasive assessment of genetic variations.
    Type: Grant
    Filed: February 27, 2017
    Date of Patent: August 11, 2020
    Assignee: Sequenom, Inc.
    Inventors: Charles R. Cantor, Grace DeSantis, Reinhold Mueller, Mathias Ehrich
  • Patent number: 10464976
    Abstract: The invention relates to neuromodulatory oligomers of the amyloid-?(1-42) protein, a particular production method, by means of which the oligomer can be obtained in a reproducible manner at high yield, the use of the oligomers as diagnostic and therapeutics agents, for the generation of oligomer-specific antibodies and for the discovery of substances which can interact with the oligomers and in the formation thereof. Corresponding methods for the production of the antibodies and for discovery of the substances are also disclosed as are the antibodies themselves and the use of the antibodies or substances as diagnostic and therapeutic agents. The invention further relates to derivatives of the oligomers and oligomers based on abbreviated forms of the amyloid-?(1-42) proteins, the production and use thereof.
    Type: Grant
    Filed: September 24, 2015
    Date of Patent: November 5, 2019
    Assignee: ABBVIE DEUTSCHLAND GMBH & CO. KG
    Inventors: Heinz Hillen, Andreas Striebinger, Carsten Krantz, Achim Moeller, Reinhold Mueller
  • Publication number: 20190231150
    Abstract: Aspects of the present disclosure generally pertain to a devices for dampening inadvertent rollout of a paper roll. Generally, the disclosed dampening device for a paper roll is a device that rests on a bottom portion of an inner surface of a paper roll when the paper roll is installed in a horizontal orientation. The dampening device relies on its weight, to provide friction to resist rollout.
    Type: Application
    Filed: January 30, 2019
    Publication date: August 1, 2019
    Inventor: Reinhold MUELLER
  • Publication number: 20190233510
    Abstract: The subject invention relates to isolated proteins, particularly monoclonal antibodies, which bind to the Nogo-66 receptor. Specifically, these antibodies have the ability to inhibit the binding of the natural ligand of the Nogo-66 receptor and neutralize the Nogo-66 receptor. These antibodies or portions thereof of the invention are useful for detecting NgR and for inhibiting NgR activity, for example in a human suffering from a disorder in which NgR or Nogo-66 activity is detrimental.
    Type: Application
    Filed: August 6, 2018
    Publication date: August 1, 2019
    Inventors: Mario Mezler, Achim Moeller, Reinhold Mueller, Bernhard K. Mueller, Tariq Ghayur, Eve H. Barlow, Martin Schmidt, Axel Meyer, Nicole Teusch
  • Publication number: 20190193679
    Abstract: Aspects of the present disclosure generally pertain to a system and method for overriding a vehicle inhibitor. This disclosure may be useful for providing an emergency override function for vehicle loan repayment enforcement systems that have wireless user interface modules, and that have become lost or inoperable when needed to generate an emergency override signal. Further, the present disclosure addresses this problem while mitigating additional system cost and additional components. This disclosure includes a method of providing an emergency override function for vehicle loan repayment enforcement systems that have wireless user interface modules, and that have become lost or inoperable when needed to generate an emergency override signal. Further this disclosure includes a method of providing a disablement override function for vehicle loan repayment enforcement systems, wired or wireless, that allows vehicle operation past the grace period in those locations where complete disablement may be limited.
    Type: Application
    Filed: October 11, 2018
    Publication date: June 27, 2019
    Inventor: Reinhold MUELLER
  • Patent number: 10040852
    Abstract: The subject invention relates to isolated proteins, particularly monoclonal antibodies, which bind to the Nogo-66 receptor. Specifically, these antibodies have the ability to inhibit the binding of the natural ligand of the Nogo-66 receptor and neutralize the Nogo-66 receptor. These antibodies or portions thereof of the invention are useful for detecting NgR and for inhibiting NgR activity, for example in a human suffering from a disorder in which NgR or Nogo-66 activity is detrimental.
    Type: Grant
    Filed: January 6, 2016
    Date of Patent: August 7, 2018
    Assignees: ABBVIE DEUTSCHLAND GMBH & CO. KG, ABBVIE INC.
    Inventors: Mario Mezler, Achim Moeller, Reinhold Mueller, Bernhard K. Mueller, Tariq Ghayur, Eve H. Barlow, Martin Schmidt, Axel Meyer, Nicole Teusch
  • Patent number: 9917781
    Abstract: Data traffic is intelligently steered by an adaptive load balancer through a software defined network (SDN) to which the load balancer is operatively coupled. The network has egress ports to which a plurality of servers is connected. The network has an SDN controller which generates statistical information concerning the network. Data traffic is steered through the SDN by the adaptive load balancer using a passive port method, a passive path, method, an active path method and an active path with quality of service (QoS) overlay method.
    Type: Grant
    Filed: February 17, 2016
    Date of Patent: March 13, 2018
    Assignee: KEMP Technologies Inc.
    Inventors: Simon Roach, Reinhold Müller
  • Patent number: 9866487
    Abstract: An adaptive load balancer intelligently steers data traffic through a software defined network (SDN) to which the load balancer is operatively coupled. The network has egress ports to which a plurality of servers is connected. The network has an SDN controller which generates statistical information concerning the network. The adaptive load balancer includes a weighted round robin scheduler module which receives client requests and, based on the statistical information generated by the SDN controller, determines a weight to be attributed to each server of the plurality of servers connected to the network. The adaptive load balancer operates in a passive port mode, a passive path mode, an active path mode and an active path with quality of service (QoS) overlay mode.
    Type: Grant
    Filed: June 4, 2015
    Date of Patent: January 9, 2018
    Assignee: KEMP Technologies Inc.
    Inventors: Simon Roach, Reinhold Müller
  • Publication number: 20170321276
    Abstract: Technology provided herein relates in part to methods, processes and apparatuses for non-invasive assessment of genetic variations.
    Type: Application
    Filed: February 27, 2017
    Publication date: November 9, 2017
    Inventors: Charles R. CANTOR, Grace DeSANTIS, Reinhold MUELLER, Mathias EHRICH
  • Patent number: 9605313
    Abstract: Technology provided herein relates in part to methods, processes and apparatuses for non-invasive assessment of genetic variations.
    Type: Grant
    Filed: March 1, 2013
    Date of Patent: March 28, 2017
    Assignee: SEQUENOM, INC.
    Inventors: Charles R. Cantor, Grace DeSantis, Reinhold Mueller, Mathias Ehrich
  • Publication number: 20170002075
    Abstract: The present application relates to isolated proteins, particularly monoclonal antibodies, in particular CDR-grafted, humanized antibodies which bind to RAGE protein. Specifically, these antibodies have the ability to inhibit the binding of RAGE to its various ligands. The antibodies or portions thereof of described in the present application are useful for treating a disease or disorder characterized by or induced by pathophysiological ligands of RAGE, for example missfolded proteins like amyloid ? and advanced glycation-end-products.
    Type: Application
    Filed: July 18, 2016
    Publication date: January 5, 2017
    Inventors: Jijie GU, Chung-Ming HSIEH, Zhen WU, Enrico L. DiGIAMMARINO, Feng LUO, Gerard B. FOX, John E. HARLAN, Martin SCHMIDT, Ralf LOEBBERT, Reinhold MUELLER, Ulrich EBERT, Volker NIMMRICH
  • Patent number: 9394363
    Abstract: The present application relates to isolated proteins, particularly monoclonal antibodies, in particular CDR-grafted, humanized antibodies which bind to RAGE protein. Specifically, these antibodies have the ability to inhibit the binding of RAGE to its various ligands. The antibodies or portions thereof of described in the present application are useful for treating a disease or disorder characterized by or induced by pathophysiological ligands of RAGE, for example missfolded proteins like amyloid ? and advanced glycation-end-products.
    Type: Grant
    Filed: November 27, 2012
    Date of Patent: July 19, 2016
    Assignees: ABBVIE DEUTSCHLAND GMBH & CO. KG, ABBVIE INC.
    Inventors: Jijie Gu, Chung-Ming Hsieh, Zhen Wu, Enrico L. DiGiammarino, Feng Luo, Gerard B. Fox, John E. Harlan, Martin Schmidt, Ralf Loebbert, Reinhold Mueller, Ulrich Ebert, Volker Nimmrich